Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group
Translating CYP2D6 genotype to metabolizer phenotype is not standardized across clinical laboratories offering pharmacogenetic (PGx) testing and PGx clinical practice guidelines, such as the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the Dutch Pharmacogenetics Working Group (DPWG...
Main Authors: | Kelly E. Caudle, Katrin Sangkuhl, Michelle Whirl‐Carrillo, Jesse J. Swen, Cyrine E. Haidar, Teri E. Klein, Roseann S. Gammal, Mary V. Relling, Stuart A. Scott, Daniel L. Hertz, Henk‐Jan Guchelaar, Andrea Gaedigk |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.12692 |
Similar Items
-
Variant Interpretation in Current Pharmacogenetic Testing
by: Sally Luvsantseren, et al.
Published: (2020-10-01) -
Use of Pharmacogenetic Drugs by the Dutch Population
by: Mohammad A. Alshabeeb, et al.
Published: (2019-07-01) -
Pharmacogenetics of antidepressants
by: Concetta eCrisafulli, et al.
Published: (2011-02-01) -
Pharmacogenetics of carbamazepine
by: N. A. Shnayder, et al.
Published: (2020-01-01) -
MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?
by: Rafael eDe La Torre, et al.
Published: (2012-11-01)